<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-20T20:22:02+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2682】JCO | 荟萃分析：局限性前列腺癌辅助性ADT相较于新辅助治疗能显著改善PFS</title>
    <updated>2020-12-20T18:57:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/x9G0dSqiJ4yvUiAvqdVL3A</id>
    <link href="https://mp.weixin.qq.com/s/x9G0dSqiJ4yvUiAvqdVL3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【潇湘肿瘤学高峰论坛】张永昌教授：全面考量靶向治疗，优选方案应对耐药</title>
    <updated>2020-12-20T18:57:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/aPm2y72v3f7M7E7RLyr4OQ</id>
    <link href="https://mp.weixin.qq.com/s/aPm2y72v3f7M7E7RLyr4OQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020 SABCS】循环肿瘤细胞监测可预测转移性乳腺癌患者的治疗疗效和预后</title>
    <updated>2020-12-20T18:57:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/WgvPNvSYPQMoZGg80J_UkQ</id>
    <link href="https://mp.weixin.qq.com/s/WgvPNvSYPQMoZGg80J_UkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>建议收藏|IARC更新癌症相关致癌因素名单</title>
    <updated>2020-12-20T18:57:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/LlVihNXvIuzTy26T8uSAsw</id>
    <link href="https://mp.weixin.qq.com/s/LlVihNXvIuzTy26T8uSAsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重点关注】第四届江苏肿瘤防治年会传来的这些消息振奋人心</title>
    <updated>2020-12-20T18:57:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/U38cP2UscaJzYdwX6sBlNw</id>
    <link href="https://mp.weixin.qq.com/s/U38cP2UscaJzYdwX6sBlNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2681】一周肺癌大事件！奥希替尼获批术后辅助治疗；ADJUVANT、CameL研究最新数据发表</title>
    <updated>2020-12-19T19:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/OZxfFKpmE6iVSnTDMFasNQ</id>
    <link href="https://mp.weixin.qq.com/s/OZxfFKpmE6iVSnTDMFasNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【潇湘肿瘤学高峰论坛】王静教授：探讨PARP抑制剂在卵巢癌中的耐药</title>
    <updated>2020-12-19T19:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/s3-1trYt9DaK7-FzN2DewQ</id>
    <link href="https://mp.weixin.qq.com/s/s3-1trYt9DaK7-FzN2DewQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究”  | 【3】探索OFS跌宕起伏的离奇经历之  EBCTCG荟萃分析（2005） 研究解读</title>
    <updated>2020-12-19T19:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/jkKH0F7Jj6EbG8atsCw9ng</id>
    <link href="https://mp.weixin.qq.com/s/jkKH0F7Jj6EbG8atsCw9ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【12月20日】绽放生命·相伴致远——诺华乳腺癌日线上会议即将召开</title>
    <updated>2020-12-19T19:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/ulxIVYJ1NC4RZBFqWrHELg</id>
    <link href="https://mp.weixin.qq.com/s/ulxIVYJ1NC4RZBFqWrHELg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《2020年CSCO软组织肉瘤诊疗指南》解读系列巡讲第九站—郑州站暨《软组织肉瘤科普指导手册》新书发布会即将盛大开幕！</title>
    <updated>2020-12-19T19:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/5MjdWx-po_FLuvlmpZyXWw</id>
    <link href="https://mp.weixin.qq.com/s/5MjdWx-po_FLuvlmpZyXWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【会议预告|淋巴瘤之晔问】淋巴瘤在线研讨会第七期</title>
    <updated>2020-12-19T19:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/iVmB7UuWiUUM8muWF06NhA</id>
    <link href="https://mp.weixin.qq.com/s/iVmB7UuWiUUM8muWF06NhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2680】“O+Y”和“D+T”大家想必都很熟悉了，今天咱们来聊聊“K+Q”</title>
    <updated>2020-12-18T19:03:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/E4FrdCxPO_MAW-wnUq7S5g</id>
    <link href="https://mp.weixin.qq.com/s/E4FrdCxPO_MAW-wnUq7S5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陆舜教授评述恩沙替尼（贝美纳®）上市意义，上海首单发售完成</title>
    <updated>2020-12-18T19:03:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/gLdT6tqXhMgOJDy-zmBpyA</id>
    <link href="https://mp.weixin.qq.com/s/gLdT6tqXhMgOJDy-zmBpyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“GIST 新时空”专栏 |高静教授解析：胃肠道间质瘤患者来源PDX模型的建立-临床病理特征与成瘤率的关系分析</title>
    <updated>2020-12-18T19:03:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/bOnpsvSWiaWS96kZ7ZM2vw</id>
    <link href="https://mp.weixin.qq.com/s/bOnpsvSWiaWS96kZ7ZM2vw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【2】探索OFS跌宕起伏的离奇经历之 IBCSG VIII 研究解读</title>
    <updated>2020-12-18T19:03:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/sBXhtNhByKG5-f-yCZxzlQ</id>
    <link href="https://mp.weixin.qq.com/s/sBXhtNhByKG5-f-yCZxzlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2679】研究者说|瑞派替尼治疗1例多次复发的直肠GIST患者带来的启示</title>
    <updated>2020-12-17T19:08:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/Y_5HYBxKydA0etB7df6xyA</id>
    <link href="https://mp.weixin.qq.com/s/Y_5HYBxKydA0etB7df6xyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MSI与MMR 不一致怎么办？</title>
    <updated>2020-12-17T19:08:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/eHHmpc3-v7yathyqYDVv-Q</id>
    <link href="https://mp.weixin.qq.com/s/eHHmpc3-v7yathyqYDVv-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>直击现场，我国首个肉瘤基础研究专业学术组织成立！</title>
    <updated>2020-12-17T19:08:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/BSaz1I3Xh6wCFK3QVPb1-w</id>
    <link href="https://mp.weixin.qq.com/s/BSaz1I3Xh6wCFK3QVPb1-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王悦虹教授：纳武利尤单抗二线治疗驱动基因阴性晚期NSCLC带来长生存获益</title>
    <updated>2020-12-17T19:08:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/FpABpWtT33jZ8B8023XCKQ</id>
    <link href="https://mp.weixin.qq.com/s/FpABpWtT33jZ8B8023XCKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>邢镨元教授畅谈RET融合阳性NSCLC国内外诊疗现状，普拉替尼前景光明或为治疗新选择</title>
    <updated>2020-12-17T19:08:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/m09vceG4E9GpjCgZf0P_Bg</id>
    <link href="https://mp.weixin.qq.com/s/m09vceG4E9GpjCgZf0P_Bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>